C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases

British Journal of Cancer

Volumn 96, Issue 2, 2007, Pages 222-225

  Wong, V K H ^a   Malik, H Z ^a   Hamady, Z Z R ^a   Al Mukhtar, A ^a   Gomez, D ^a   Prasad, K R ^a   Toogood, G J ^a   Lodge, J P A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

C reactive protein; Colorectal liver metastases; Inflammatory response; Survival

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LABORATORY TEST; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 33846497237     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603558     Document Type: Article

References (32)

1. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545
2. Cancer Research UK Information Centre (2003) CancerStats. http//:info.cancerresearchuk.org/cancerstats
3. Canna K, McArdle PA, McMillan DC, McNicol A-M, Smith GW, McKee RF, McArdle CS (2005) The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92: 651-654
4. Chauhan D, Kharbanda S, Ogata A, Urashima M, Teoh G, Robertson M, Kufe DW, Anderson KC (1997) Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood 89(1): 227-234
5. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860-867
6. Crumley ABC, McMillan DC, McKernan M, Going JJ, Shearer CJ, Stuart RC (2006) An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 94: 1568-1571
7. Finch RJB, Malik HZ, Hamady ZZR, Al-Mukhtar A, Adair R, Prasad KR, Lodge JPA, Toogood GJ (2006) Outcome following liver resection for colorectal liver metastases: effect of type of resection. Br J Surg (in press)
8. Fondevila C, Metges JP, Fuster J, Grau JJ, Palacin A, Castells A, Volant A, Pera M (2004) p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer 90: 206-215
9. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH, Brennan MF (1997) Liver resection for colorectal metastases. J Clin Oncol 15: 938-946
10. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318
11. Frassanito MA, Cusmai A, Iodice G, Dammaco F (2001) Autocrine interleukin-6 production and highly malignant multiple myeloma: Relation with resistance to drug-induce apoptosis. Blood 97: 483-489
12. Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Weinstein S, Wood RJ, Virtamo J, Taylor PR, Albanes D, Sinha R (2006) A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res 66: 2483-2487
13. Hamady ZZR, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JPA (2006) Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: A critical appraisal of the 1 cm rule. Eur J Surg Onco 32: 557-563
14. Jee SH, Shen SC, Chiu HC, Tsai WL, Kuo M (2001) Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases antiapoptotic activity and tumorigenic potency. Oncogene 20: 198-208
15. McMillan DC, Canna K, McArdle CS (2003) Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90: 215-219
16. McMillan DC, Wotherspoon HA, Fearon KC, Sturgeon C, Cooke TG, McArdle CS (1995) A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170: 319-322
17. Miki C, Konishi N, Ojima E, Hatada T, Inous Y, Kusunoki M (2004) C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci 49: 970-976
18. Mukherjee D, Nissen SE, Topol EJ (2001) Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286: 954-959
19. Nordlinger B, Vaillant JC, Guiguet M, Balladur P, Paris F, Bachellier P, Jaeck D (1994) Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie.. J Clin Oncol 12: 1491-1496
20. Nozoe T, Saeki H, Sugimachi K (2001) Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 182: 197-201
21. Okano K, Maeba T, Modoguchi A, Ishimura K, Karasawa Y, Izuishi K, Goda F, Usuki H, Wakabayashi H, Maeta H (2003) Lymphocytic infiltration surrounding liver metastases from colorectal cancer. J Surg Oncol 82(1): 28-33
22. Seifert JK, Bottger TC, Weigel TF, Gonner U, Junginger T (2000) Prognostic factors following liver resection for hepatic metastases from colorectal cancer. Hepato-Gastroenterology 47: 239-246
23. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Canc 94: 982-999
24. Steele Jr G, Bleday R, Mayer RJ, Lindblad A, Petrelli N, Weaver D (1991) A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastointestinal Tumor Study Group Protocol 6584. J Clin Oncol 9: 1105-1112
25. Takahashi S, Inoue K, Konishi M, Nakagouri T, Kinoshita T (2003) Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases. Surgery 133: 627-634
26. Tanaka K, Shimada H, Fujii Y, Endo I, Sekido H, Togo S, Ike H (2004) Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Arch Surg 389: 371-379
27. Tanigawa N, Amaya N, Matsumura M, Shimomatsuya T (1997) Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 15: 826-832
28. Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252-266
29. Vidal-Vanaclocha F, Amezaga C, Asumendi A, Kaplanski G, Dinarello CA (1994) Interleukin 1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res 54: 2667-2672
30. Vidal-Vanaclocha F, Fantuzzi G, Mendoza L, Fuentes AM, Anasagasti MJ, Martin J, Carrascal T, Walsh P, Reznikov LL, Kim SH, Novick D, Rubinstein M, Dinarello CA (2000) IL-18 regulates IL-1b-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci USA 97: 734-739
31. Xavier P, Belo L, Beires J, Rebelo I, Martinez-de-Oliveira J, Lunet N, Barros H (2006) Serum levels of VEGF and TNF-a and their association with Creactive protein in patients with endometriosis. Arch Gynecol Obstet 273: 227-231
32. Yau M, Kargman S, Lam EC, Kelly CR, Zheng Y, Luk P, Kwong E, Evans JF, Wolfe MM (2003) Inhibition of cycooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Cancer Res 63: 586-592